Drospirenone with 17β-estradiol in the postmenopausal woman with hypertension

@article{White2007DrospirenoneW1,
  title={Drospirenone with 17$\beta$-estradiol in the postmenopausal woman with hypertension},
  author={W. White},
  journal={Climacteric},
  year={2007},
  volume={10},
  pages={25 - 31}
}
  • W. White
  • Published 2007
  • Medicine
  • Climacteric
Hypertension is one of the most important risk factors for the development of cardiovascular disease. The prevalence of hypertension increases with age and also after the menopause; therefore, blood pressure monitoring and effective control of elevated blood pressure are very important in postmenopausal women. The knowledge that aldosterone is a dual cardiovascular and endocrine hormone has blurred the once distinct boundary between gynecology and cardiovascular medicine. Aldosterone plays a… Expand
Cardiovascular Risk During the Menopause
Alternative regimens for endometrial protection – where are we now?
  • N. Panay, A. Fenton
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2011
Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension.
Effect of aerobic exercise on blood lipid levels in postmenopausal women
Climacteric Commentaries
...
1
2
...

References

SHOWING 1-10 OF 36 REFERENCES
Recent studies with eplerenone, a novel selective aldosterone receptor antagonist.
  • E. Mcmahon
  • Medicine
  • Current opinion in pharmacology
  • 2001
The influence of menopause on blood pressure.
...
1
2
3
4
...